Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/20135
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dockrell, HM | - |
dc.contributor.author | Smith, SG | - |
dc.date.accessioned | 2020-01-29T13:17:21Z | - |
dc.date.available | 2017-09-13 | - |
dc.date.available | 2020-01-29T13:17:21Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | Frontiers in Immunology, 2017, 8 (SEP) | en_US |
dc.identifier.issn | http://dx.doi.org/10.3389/fimmu.2017.01134 | - |
dc.identifier.issn | 1664-3224 | - |
dc.identifier.uri | http://bura.brunel.ac.uk/handle/2438/20135 | - |
dc.description.abstract | © 2017 Dockrell and Smith. A number of new tuberculosis (TB) vaccines have been or are entering clinical trials, which include genetically modified mycobacteria, mycobacterial antigens delivered by viral vectors, or mycobacterial antigens in adjuvant. Some of these vaccines aim to replace the existing BCG vaccine but others will be given as a boosting vaccine following BCG vaccination given soon after birth. It is clear that the existing BCG vaccines provide incomplete and variable protection against pulmonary TB. This review will discuss what we have learnt over the last 20 years about how the BCG vaccine induces specific and non-specific immunity, what factors influence the immune responses induced by BCG, and progress toward identifying correlates of immunity against TB from BCG vaccination studies. There is still a lot to learn about the BCG vaccine and the insights gained can help the development of more protective vaccines. | en_US |
dc.description.sponsorship | he European Commission within Horizon2020 TBVAC2020 (grant number H2020 PHC-643381); Medical Research Council (project grant number MR/K019708). | en_US |
dc.language.iso | en | en_US |
dc.publisher | Frontiers Media | en_US |
dc.title | What have we learnt about BCG vaccination in the last 20 years? | en_US |
dc.type | Article | en_US |
dc.identifier.doi | http://dx.doi.org/10.3389/fimmu.2017.01134 | - |
dc.relation.isPartOf | Frontiers in Immunology | - |
pubs.issue | SEP | - |
pubs.publication-status | Published | - |
pubs.volume | 8 | - |
dc.identifier.eissn | 1664-3224 | - |
Appears in Collections: | Dept of Life Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | 271.84 kB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.